ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Menopausal hormone therapy with estradiol and progesterone vs other estrogensand progestins
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 233046" data-attributes="member: 13851"><p><strong>Figure 2. <u>Outcomes with E2 versus CEE and P4 versus synthetic progestogens</u>. (A) Cardiovascular outcome and breast cancer risks with estrogens. (B) Cardiovascular outcome risk with progestogens. (C) Breast cancer risk with progestogens. AF: atrial fibrillation; CEE: conjugated equine estrogens; CHD: coronary heart disease; CI: confidence interval; CMA: chlormadinone acetate; CPA: cyproterone acetate; CVD: cardiovascular disease; der: derivatives; DYD: dydrogesterone; E: estrogen; E2: estradiol; Es: estrogens; HR: hazard ratio; LNG: levonorgestrel; MACE: major adverse cardiac event; MDG: medogestone; MPA: medroxyprogesterone acetate; NETA: norethisterone acetate; NOMAC: nomegestrol acetate; OR: odds ratio; P: progestin; P4: progesterone; PMG: promegestone; RR: relative risk; TD: transdermal; VTE: venous thromboembolism.</strong></p><p><strong>[ATTACH=full]25337[/ATTACH]</strong></p></blockquote><p></p>
[QUOTE="madman, post: 233046, member: 13851"] [B]Figure 2. [U]Outcomes with E2 versus CEE and P4 versus synthetic progestogens[/U]. (A) Cardiovascular outcome and breast cancer risks with estrogens. (B) Cardiovascular outcome risk with progestogens. (C) Breast cancer risk with progestogens. AF: atrial fibrillation; CEE: conjugated equine estrogens; CHD: coronary heart disease; CI: confidence interval; CMA: chlormadinone acetate; CPA: cyproterone acetate; CVD: cardiovascular disease; der: derivatives; DYD: dydrogesterone; E: estrogen; E2: estradiol; Es: estrogens; HR: hazard ratio; LNG: levonorgestrel; MACE: major adverse cardiac event; MDG: medogestone; MPA: medroxyprogesterone acetate; NETA: norethisterone acetate; NOMAC: nomegestrol acetate; OR: odds ratio; P: progestin; P4: progesterone; PMG: promegestone; RR: relative risk; TD: transdermal; VTE: venous thromboembolism. [ATTACH type="full"]25337[/ATTACH][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Menopausal hormone therapy with estradiol and progesterone vs other estrogensand progestins
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top